Carlsmed, Inc. (NASDAQ: CARL) AI-Powered Stock Analysis
See how Carlsmed, Inc. scores across key metrics like financial growth, valuation, and market position on the NASDAQ, using AI-driven evaluation.
CARL●NASDAQ
HealthcareMedical - Devices
$12.59
$0.07(0.55%)
U.S. Market opens in 45h 46m
Carlsmed, Inc. (NASDAQ: CARL) AI-Powered Stock Analysis
See how Carlsmed, Inc. scores across key metrics like financial growth, valuation, and market position on the NASDAQ, using AI-driven evaluation.
Model Information
The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continuously improving this model to increase accuracy and performance.Read our Full DisclaimerCarlsmed, Inc. (NASDAQ: CARL) Stock Overall Grade
Carlsmed, Inc.'s grade for its NASDAQ listing, based on a comprehensive AI analysis of financial metrics, growth potential, and market position.
Z
Grade Breakdown by Metric
See how each financial and market factor contributes to Carlsmed, Inc.'s overall NASDAQ stock rating.
Forecast
C+Score
56/100Financial Growth
A+Score
90/100Fundamental Growth
DScore
36/100Key Ratios
C+Score
55/100Sector Comparison
BScore
65/100Industry Comparison
C+Score
50/100S&P 500 Benchmark
A+Score
98/100Analyst Consensus
B+Score
75/100Carlsmed, Inc. (NASDAQ: CARL) AI-Powered Stock Analysis
On the NASDAQ, CARL demonstrates Good performance with an overall Forecast Score of 56/100 (C+), reflecting weak confidence in its potential. Financial Growth (90/100, A+) and Fundamental Growth (36/100, D) highlight its stability, while Key Ratios (55/100, C+) and Sector Comparison (65/100, B) indicate solid positioning. Compared to broader benchmarks like the S&P 500 (98/100, A+), the NASDAQ-listed stock shows competitive strength. Analyst Consensus (75/100, B+) suggests Moderate divergence in outlook.(NASDAQ: CARL) Component Analysis Explained
Understand the key factors behind each Carlsmed, Inc. (NASDAQ: CARL) stock grade, including financials, comparisons, and forecasts.